Nial J. Wheate
Nial J. Wheate (born 1976) is an Australian pharmaceutical chemist and author who works at the University of Sydney in Australia.
Career
After graduating from Copland College in Canberra, Wheate was commissioned as an officer in the Royal Australian Navy. He received a Bachelor of Science degree with a double major in chemistry from the Australian Defence Force Academy, graduating in 1997 with First Class Honours. Following a brief appointment as a Visiting Military Scholar, he completed a PhD in 2001 under the supervision of Associate Professor J. Grant Collins at the University of New South Wales' School of Physical, Environmental, and Mathematical Sciences. His thesis was titled Platinum Anticancer Drugs.
He was later assigned to the School of Air Combat at RAAF Base East Sale. He was accepted into the Air Coordination and Policy Agency, the Joint Health Support Agency, and the Sea Power Centre - Australia. He left the Navy in 2005 and was appointed a Senior Fellow in the School of Biomedical and Health Sciences at the University of Western Sydney. He later became a lecturer in medicinal chemistry at the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde in Glasgow, Scotland. He is an Associate Professor in the Faculty of Medicine and Health at the University of Sydney. In 2013, he was appointed Head of Cancer Research within the Faculty of Pharmacy. In March 2019, he joined the board of Canngea Pty Ltd, an Australian medicinal cannabis manufacturer, as Science Director.
Research Interests
Wheate's research focuses on metal-based drugs. His research group's work includes drug design and synthesis, encapsulation of drugs in macrocycles, attachment of drugs to nanoparticles, drug solid-state stability and , drug mechanisms of action, improving drug solubility through the formation of cocrystals, drug metabolism, drug pre-formulation and formulation, and drug-excipient interactions in various dosage forms. His work has included the development of magnetically directed drug delivery for platinum drugs.
Wheate's work has focused on multinuclear platinum-based drugs and the potential applications of cucurbiturils for drug delivery.
In 2013, Wheate was elected a Fellow of the Royal Australian Chemical Institute in recognition of his work in cancer research and is also a senior fellow of the Higher Education Academy.
Wheate was previously an associate editor of the Australian Journal of Chemistry.
Other contributions
Wheate has also published in a variety of other areas, including military justice, naval history, weapons of mass destruction, and he has written a novel titled Whikatak Island.
Career
After graduating from Copland College in Canberra, Wheate was commissioned as an officer in the Royal Australian Navy. He received a Bachelor of Science degree with a double major in chemistry from the Australian Defence Force Academy, graduating in 1997 with First Class Honours. Following a brief appointment as a Visiting Military Scholar, he completed a PhD in 2001 under the supervision of Associate Professor J. Grant Collins at the University of New South Wales' School of Physical, Environmental, and Mathematical Sciences. His thesis was titled Platinum Anticancer Drugs.
He was later assigned to the School of Air Combat at RAAF Base East Sale. He was accepted into the Air Coordination and Policy Agency, the Joint Health Support Agency, and the Sea Power Centre - Australia. He left the Navy in 2005 and was appointed a Senior Fellow in the School of Biomedical and Health Sciences at the University of Western Sydney. He later became a lecturer in medicinal chemistry at the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde in Glasgow, Scotland. He is an Associate Professor in the Faculty of Medicine and Health at the University of Sydney. In 2013, he was appointed Head of Cancer Research within the Faculty of Pharmacy. In March 2019, he joined the board of Canngea Pty Ltd, an Australian medicinal cannabis manufacturer, as Science Director.
Research Interests
Wheate's research focuses on metal-based drugs. His research group's work includes drug design and synthesis, encapsulation of drugs in macrocycles, attachment of drugs to nanoparticles, drug solid-state stability and , drug mechanisms of action, improving drug solubility through the formation of cocrystals, drug metabolism, drug pre-formulation and formulation, and drug-excipient interactions in various dosage forms. His work has included the development of magnetically directed drug delivery for platinum drugs.
Wheate's work has focused on multinuclear platinum-based drugs and the potential applications of cucurbiturils for drug delivery.
In 2013, Wheate was elected a Fellow of the Royal Australian Chemical Institute in recognition of his work in cancer research and is also a senior fellow of the Higher Education Academy.
Wheate was previously an associate editor of the Australian Journal of Chemistry.
Other contributions
Wheate has also published in a variety of other areas, including military justice, naval history, weapons of mass destruction, and he has written a novel titled Whikatak Island.
Comments